Edition:
United States

Oragenics Inc (OGEN.N)

OGEN.N on New York Stock Exchange

0.48USD
24 Apr 2019
Change (% chg)

-- (--)
Prev Close
$0.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,867
52-wk High
$3.73
52-wk Low
$0.39

About

Oragenics, Inc. develops, markets and sells probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora. The Company is focused on offering antibiotics against infectious disease and on developing treatments for oral mucositis. It is engaged in developing its antibiotic... (more)

Overall

Beta: 1.57
Market Cap(Mil.): $22.59
Shares Outstanding(Mil.): 46.11
Dividend: --
Yield (%): --

Financials

  OGEN.N Industry Sector
P/E (TTM): -- 62.05 62.41
EPS (TTM): -1.36 -- --
ROI: -72.90 12.20 11.81
ROE: -153.18 13.14 12.64

Earnings vs. Estimates